OR WAIT null SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
J. Mark Wiggins is owner and compendial consultant with Global Pharmacopoeia Solutions LLC.
Joseph A. Albanese, director of Analytical Strategy and Compliance at Janssen Research and Development, LLC
This article provides an end-to-end compendial framework to understand why compliance with pharmacopoeia standards is challenging.
Related Content: